Optum Health: Owning the CareThin moat

UnitedHealth Group (UNH) — moat facet

Optum Health was built to profit from managing costs and instead lost money when costs rose, because it carried the same risk as the insurer.

Optum Health was meant to be UnitedHealth's answer to rising medical costs: own the doctors, take a fixed payment per patient, and keep the savings from better care. In 2024 it earned $6,902 million on the 2026 segment basis; in 2025 it lost $1,115 million1. On the old basis its revenue was $101,957 million in 2025, and about 62% of it came from UnitedHealthcare23.

Optum Health earnings from operations ($M)4,46220216,03220226,56020237,7702024-2782025UnitedHealth Group Forms 10-K FY2023 and FY2025, pre-2026 segment basis
Growth for years, then a loss.

The model failed in 2025 for a simple reason. Under value-based arrangements the clinics bear medical cost risk, so when costs rose they lost money at the same time as the insurer. A report attributed the negative margins to rising costs and federal policies that restricted payments4.

The response has been to shrink and reprice. The company cited the strategic right-sizing of Optum Health in its 2026 outlook5, served about 700,000 fewer value-based patients in the second quarter6, and sold part of its Florida clinics to a private-equity partner7. Earnings have come back: $1,190 million in the second quarter, a 5.1% margin8.

The chief financial officer expects margins of about 2% in 2026, 4% in 2027 and 6% in 20289.

The leadership changed with the strategy. Patrick Conway became chief executive of Optum in May 202510, and Krista Nelson leads Optum Health11. The segment's capital base is large: $100,991 million of assets at the end of 2025 on the old basis12, much of it goodwill from the practices, clinics and home-health businesses UnitedHealth bought.

This is a thin moat. Owning clinics gives local strength and data, but the business carries the same risk as the insurer and competes for doctors with everyone else. The margin path is the test: reaching 4% in 2027 would say the model has been repaired; falling short would say value-based care at this scale does not pay.

Moat trajectory: Widening

From a Q4 2025 loss to a 5.1% margin in Q2 2026.

The number that tests this moat
Reported
Optum Health earnings from operations, latest quarter
$1,190M (Q2 2026) vs $429M

The care business's recovery; a return to losses would mean the repricing failed.

Source: UnitedHealth Group Q2 2026 results release ↗
Aspects of the moat
DIG DEEPER 01
From a $6.9 Billion Profit to a $1.1 Billion Loss
Optum Health swung from a $6.9 billion profit to a $1.1 billion loss in one year, which is what value-based care looks like when costs outrun the…
DIG DEEPER 02
Seven Hundred Thousand Fewer Patients
Optum Health became profitable again in 2026 by serving about 700,000 fewer value-based patients.
DIG DEEPER 03
WellMed, Florida and a Private-Equity Partner
UnitedHealth sold part of its Florida WellMed clinics to TPG, which shows it now treats clinic ownership as capital to share.
DIG DEEPER 04
Amedisys and Care in the Home
UnitedHealth paid about $3.3 billion for Amedisys and had to sell 164 locations to get the deal past the Justice Department.
⚠ Threats to the moat
⚠ THREAT 01
Optum Health Revenue Is Mostly UnitedHealthcare's
Sixty-two percent of Optum Health's revenue comes from UnitedHealthcare, so the clinics shrink whenever the insurer does.
⚠ THREAT 02
The Doctors Are Contested
UnitedHealth employs about 165,000 clinicians and still warns of heightened competition for every physician practice.
References
  1. ReportedIn 2024 it earned $6,902 million on the 2026 segment basis; in 2025 it lost $1,115 million.
    UnitedHealth Group first-quarter 2026 results release, Form 8-K exhibit 99.1 - including the recast of 2024 and 2025 segment results for the Optum Financial realignment. — Q1 2026 · publ. 21 April 2026 · source ↗
  2. ReportedOn the old basis its revenue was $101,957 million in 2025, and about 62% of it came from UnitedHealthcare.
    UnitedHealth Group Form 10-K for fiscal 2025 - Item 7 MD&A: consolidated and segment results, medical care ratio, membership and operating metrics. — FY2025 · publ. 2 March 2026 · source ↗
  3. Moat Explorer calcOn the old basis its revenue was $101,957 million in 2025, and about 62% of it came from UnitedHealthcare.
    Moat Explorer calculation from UnitedHealth Group's reported figures ($ millions unless stated). External revenue by segment = segment revenue less affiliated revenue (10-K segment notes): 2021 UnitedHealthcare 222,899; Optum Health 54,065 - 29,234 = 24,831; Optum Insight 12,199 - 7,867 = 4,332; Optum Rx 91,314 - 55,779 = 35,535; total 287,597. 2022: 249,741; 71,174 - 40,883 = 30,291; 14,581 - 9,288 = 5,293; 99,773 - 60,936 = 38,837; total 324,162. 2023: 281,360; 95,319 - 57,696 = 37,623; 18,932 - 10,896 = 8,036; 116,087 - 71,484 = 44,603; total 371,622. 2024: 298,208; 105,358 - 63,883 = 41,475; 18,757 - 11,881 = 6,876; 133,231 - 79,512 = 53,719; total 400,278. 2025: 344,903; 101,957 - 63,615 = 38,342; 19,417 - 12,948 = 6,469; 154,726 - 96,873 = 57,853; total 447,567. Q2 2026 (2026 basis): 86,017; 23,472 - 14,353 = 9,119; 5,402 - 3,556 = 1,846; 38,292 - 23,242 = 15,050; total 112,032; Optum external 9,119 + 1,846 + 15,050 = 26,015. Optum external revenue = Optum revenue less corporate eliminations: 155,565 - 90,867 = 64,698 (2021); 182,768 - 108,347 = 74,421 (2022); 226,635 - 136,373 = 90,262 (2023); 252,957 - 150,887 = 102,070 (2024); 270,620 - 167,956 = 102,664 (2025); 102,664 / 102,070 - 1 = 0.6%. Optum revenue from inside the group: 90,867 / 155,565 = 58.4%; 108,347 / 182,768 = 59.3%; 136,373 / 226,635 = 60.2%; 150,887 / 252,957 = 59.6%; 167,956 / 270,620 = 62.1%; Q2 2026 39,648 / 65,663 = 60.4%. Affiliated shares 2025: Optum Health 63,615 / 101,957 = 62%; Optum Insight 12,948 / 19,417 = 67%; Optum Rx 96,873 / 154,726 = 63%. Affiliated revenue as share of UnitedHealthcare revenue 167,956 / 344,903 = 49%. Segment shares of consolidated revenue 2025: UnitedHealthcare 344,903 / 447,567 = 77%; Optum Rx 57,853 / 447,567 = 12.9%; Optum Health 38,342 / 447,567 = 8.6%; Optum Insight 6,469 / 447,567 = 1.4%. Q2 2026 UnitedHealthcare 86,017 / 112,032 = 76.8%. Compound growth 2021-2025: UnitedHealthcare (344,903 / 222,899)^(1/4) - 1 = 11.5%; Optum Rx external (57,853 / 35,535)^(1/4) - 1 = 13.0%. Segment margins: UnitedHealthcare 11,975 / 222,899 = 5.4% (2021), 14,379 / 249,741 = 5.8% (2022); Optum Rx 4,135 / 91,314 = 4.5% (2021), 4,436 / 99,773 = 4.4% (2022); Optum Insight 3,398 / 12,199 = 27.9% (2021), 3,588 / 14,581 = 24.6% (2022); Optum Health H1 2026 2,331 / 47,581 = 4.9%. Optum earnings decline 16,703 - 9,539 = 7,164, 7,164 / 16,703 = 42.9%. Optum Health H1 2026 revenue 47,581 / 49,562 - 1 = -4.0%; earnings 2,331 / 1,840 - 1 = +26.7%; affiliated revenue Q2 14,353 / 15,845 - 1 = -9.4%. Optum Health 2025 recast margin -1,115 / 100,051 = -1.1%; 2024 6,902 / 103,516 = 6.7%. Medical care ratio 2015-2019 from EDGAR XBRL medical costs / premiums: 103,875 / 127,163 = 81.7%; 117,038 / 144,118 = 81.2%; 130,036 / 158,453 = 82.1%; 145,403 / 178,087 = 81.6%; 156,440 / 189,699 = 82.5%. Premiums 127,163 (2015) and 257,157 (2022). Operating earnings 11,021 (2015, XBRL). One point of medical care ratio on 2025 premiums: 352,229 x 1% = 3,522; 3,522 / 18,964 = 18.6% of operating earnings. Q2 2026 favorable development 860 / 86,956 premiums = 1.0 point. Membership: commercial risk-based 8,845 - 7,655 = 1,190 thousand, 1,190 / 8,845 = 13.5%; Medicare Advantage 8,445 - 7,565 = 880 thousand, 880 / 8,445 = 10.4%; Medicaid 7,845 - 6,780 = 1,065 thousand, 1,065 / 7,845 = 13.6%; Part D stand-alone (3,315 - 2,710) / 3,315 = 18.3%. Community & State revenue per year-end Medicaid member 75,004 / 7.845 = 9,561 dollars (2023); 94,390 / 7.380 = 12,790 dollars (2025). Optum Rx quarterly scripts (414 - 387) / 414 = 6.5%. Optum Insight backlog: external 32.8 - 12.5 = 20.3 bn (2024), 31.1 - 12.9 = 18.2 bn (2025), change -10.3%; affiliated share 12.5 / 32.8 = 38%, 12.9 / 31.1 = 41%. Cyberattack provider loans 9,033 - 4,514 - 1,680 = 2,839 not yet repaid at end-2025. Market value against peers: 108.78 + 86.37 + 70.16 + 45.67 + 30.59 + 10.07 = 351.64 bn; 338.03 / 351.64 = 96%. CMS premium revenue 44% x 447,567 = 196,929 (about 197 bn); all other 447,567 - 196,929 = 250,638. Medicare & Retirement share of UnitedHealthcare revenue Q2 2026: 42,390 / 86,017 = 49.3%. Premiums share of revenue Q2 2026: 86,956 / 112,032 = 77.6%. Capital returns 2025: dividends 7,916 + buybacks 5,545 = 13,461; 13,461 / 12,056 = 112% of net earnings; free cash flow 19,697 - 3,622 = 16,075; 13,461 / 16,075 = 84%. Goodwill 44,453 (2015, XBRL) and 110,499 (2025); goodwill plus other intangibles 110,499 + 20,474 = 130,973; 130,973 / 309,581 = 42.3% of assets. Long-term debt 25,331 (2015, XBRL). Interest expense / operating earnings: 3,246 / 32,358 = 10.0% (2023); 4,002 / 18,964 = 21.1% (2025). Rate sensitivity net 345 - 273 = 72. Investment income (3,920 - 5,202) / 5,202 = -24.6%; 4,089 / 371,622 = 1.1% of 2023 revenue. Net interest-bearing debt: 6,069 + 72,320 - 28,121 = 50,268 (Dec 2025); 3,827 + 69,501 - 31,468 = 41,860 (Jun 2026). 2025 guidance: original adjusted EPS midpoint (29.50 + 30.00) / 2 = 29.75; April (26.00 + 26.50) / 2 = 26.25; actual 16.35 / 29.75 - 1 = -45%. 2026 adjusted EPS midpoint (19.50 + 20.00) / 2 = 19.75. Progress vs 2026 guidance: operating earnings 16,981 / 25,450 = 66.7%. Q2 2026 operating earnings 7,991 / 5,150 - 1 = +55%. Gross segment revenue 2025: 344,903 + 101,957 + 19,417 + 154,726 = 621,003; less Optum eliminations 5,480 and corporate eliminations 167,956 = 447,567. Medical costs 313,995 / 264,185 - 1 = 18.9%; medical costs payable 39,337 / 34,224 - 1 = 14.9%. Commercial risk-based members 8,165 - 7,725 = 440 thousand (Q1 2026), 7,725 - 7,655 = 70 thousand (Q2 2026). Medicaid 7,380 - 6,780 = 600 thousand (six months to June 2026); 7,845 - 7,380 = 465 thousand (2023-2025). Optum Rx Q4 2025 share of year 2,885 / 7,193 = 40%. Goodwill 110,499 - 106,734 = 3,765. Total debt 6,069 + 72,320 = 78,389. Dividend at 9.28 x 897.6 million shares = 8,330, 8,330 / 16,750 = 50%. Year-end P/E 2015-2020: 19.3, 21.7, 20.2, 20.0, 20.1, 21.6 (market value / net earnings). H1 2026 medical care ratio 148,847 / 174,517 = 85.3%. Part D stand-alone 2,740 - 2,710 = 30 thousand (Q2 2026). Rounded external revenue ($bn): Optum Rx 35.5, 38.8, 44.6, 53.7, 57.9 (2021-2025), 15.1 (Q2 2026); Optum Health 24.8, 30.3, 37.6, 41.5, 38.3, 9.1 (Q2 2026); Optum Insight 4.3, 5.3, 8.0, 6.9, 6.5, 1.8 (Q2 2026); Optum 64.7, 74.4, 90.3, 102.1, 102.7; net debt 50.3 and 41.9; total debt 78.4; UnitedHealthcare revenue 222.9, 249.7, 281.4, 298.2, 344.9. Optum 2026 guidance 13,450 / 9,539 - 1 = +41%. Corporate eliminations Q2 39,648 / 41,712 - 1 = -4.9%. Net interest-bearing debt / total equity 50,268 / 100,090 = 0.50. Valuation: 2026 net margin implied by guidance 16,750 / 439,000 = 3.8%; 2023 net margin 6.0% x 439.0 bn = 26.3 bn; 338.03 / 26.34 = 12.8 times - ratios, growth rates and membership changes. — 2015-2026 · publ. September 2026 · source ↗
    Method: Arithmetic on figures reported in UnitedHealth Group's Forms 10-K and 10-Q, results releases, SEC EDGAR XBRL and market data; operands shown in the source line.
  4. ReportedA report attributed the negative margins to rising costs and federal policies that restricted payments.
    Insurance Journal (Bloomberg), 'UnitedHealth Sells Interest in Florida WellMed Clinics to TPG' - including the CFO's Optum Health margin path. — September 2026 · publ. 9 September 2026 · source ↗
  5. ReportedThe company cited the strategic right-sizing of Optum Health in its 2026 outlook, served about 700,000 fewer value-based patients in the second quarter, and sold part of its Florida clinics to a private-equity partner.
    UnitedHealth Group fourth-quarter and full-year 2025 results release and 2026 outlook, Form 8-K exhibit 99.1. — FY2025 · publ. 27 January 2026 · source ↗
  6. ReportedThe company cited the strategic right-sizing of Optum Health in its 2026 outlook, served about 700,000 fewer value-based patients in the second quarter, and sold part of its Florida clinics to a private-equity partner.
    UnitedHealth Group second-quarter 2026 results release, Form 8-K exhibit 99.1 - segment results, operating metrics and people served. — Q2 2026 · publ. 16 July 2026 · source ↗
  7. ReportedThe company cited the strategic right-sizing of Optum Health in its 2026 outlook, served about 700,000 fewer value-based patients in the second quarter, and sold part of its Florida clinics to a private-equity partner.
    Insurance Journal (Bloomberg), 'UnitedHealth Sells Interest in Florida WellMed Clinics to TPG' - including the CFO's Optum Health margin path. — September 2026 · publ. 9 September 2026 · source ↗
  8. ReportedEarnings have come back: $1,190 million in the second quarter, a 5.1% margin.
    UnitedHealth Group second-quarter 2026 results release, Form 8-K exhibit 99.1 - consolidated results, medical care ratio, cash flow, balance sheet and the raised 2026 outlook. — Q2 2026 · publ. 16 July 2026 · source ↗
  9. ReportedThe chief financial officer expects margins of about 2% in 2026, 4% in 2027 and 6% in 2028.
    Insurance Journal (Bloomberg), 'UnitedHealth Sells Interest in Florida WellMed Clinics to TPG' - including the CFO's Optum Health margin path. — September 2026 · publ. 9 September 2026 · source ↗
  10. ReportedPatrick Conway became chief executive of Optum in May 2025, and Krista Nelson leads Optum Health.
    UnitedHealth Group Form 10-K for fiscal 2025 - Item 1 business: segments, products, people served and leadership. — FY2025 · publ. 2 March 2026 · source ↗
  11. ReportedPatrick Conway became chief executive of Optum in May 2025, and Krista Nelson leads Optum Health.
    Insurance Journal (Bloomberg), 'UnitedHealth Sells Interest in Florida WellMed Clinics to TPG' - including the CFO's Optum Health margin path. — September 2026 · publ. 9 September 2026 · source ↗
  12. ReportedThe segment's capital base is large: $100,991 million of assets at the end of 2025 on the old basis, much of it goodwill from the practices, clinics and home-health businesses UnitedHealth bought.
    UnitedHealth Group Form 10-K for fiscal 2025 - financial statements and notes: segment note, CMS concentration, balance sheet, cash flow and capital. — FY2025 · publ. 2 March 2026 · source ↗
Sources
Generated September 26, 2026